a 2016

The expression of CD20 on malignant B cells is regulated by chemokine signaling through the CXCR4/SDF1 axis: implications for targeting the microenvironmental interactions.

PAVLASOVÁ, Gabriela; Marek BORSKÝ; Václav ŠEDA; Kateřina ČERNÁ; Jitka OSIČKOVÁ et. al.

Basic information

Original name

The expression of CD20 on malignant B cells is regulated by chemokine signaling through the CXCR4/SDF1 axis: implications for targeting the microenvironmental interactions.

Authors

PAVLASOVÁ, Gabriela; Marek BORSKÝ; Václav ŠEDA ORCID; Kateřina ČERNÁ; Jitka OSIČKOVÁ; Michael DOUBEK; Yvona BRYCHTOVÁ; Jiří MAYER; Šárka POSPÍŠILOVÁ; M. DAVIDS; J. BROWN and Marek MRÁZ ORCID

Edition

Cancer Research (2016); 76 (14S): 3291 (AACR Annual Meeting; New Orleans, USA), 2016

Other information

Type of outcome

Conference abstract

Confidentiality degree

is not subject to a state or trade secret

Organization unit

Central European Institute of Technology
Changed: 20/12/2016 09:37, Mgr. Eva Špillingová

Links

ED1.1.00/02.0068, research and development project
Name: CEITEC - central european institute of technology
MUNI/A/1028/2015, interní kód MU
Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit III (Acronym: VýDiTeHeMa III)
Investor: Masaryk University, Category A
16-29622A, interní kód MU
(CEP code: NV16-29622A)
Name: Vliv terapeutické inhibice BCR signalizace na genovou expresi u B buněčných malignit a její prognostický a prediktivní význam
Investor: Ministry of Health of the CR
306242, interní kód MU
Name: NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia (Acronym: NGS-PTL)
Investor: European Union, Cooperation
4SGA8684, interní kód MU
Name: The role of microRNAs in the biology of B cell leukemias and lymphomas (Acronym: miRNA in CLL)
Investor: South-Moravian Region